General / Press Release
Change in SEQENS’ shareholding structure
SEQENS is now stronger, more focused and positioned as one of the world’s leading players in pharmaceutical solutions and specialty ingredients 3 new…
Read moreNewsroom
General
New investments in China
On Thursday, April 6, 2023, during the plenary session of the Franco-Chinese Business Council in Beijing and in the presence of the President of…
Read more
Events / General
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
The Seqens group has announced today that it has opened a state-of-the-art, 1,500 sqm R&D center in Devens, Mass., to serve as one…
Read more
Protéus
Protéus by Seqens, expertise partner of the virtual congress Protein Engineering Connect
Protéus by Seqens sponsored the virtual congress Protein Engineering Connect. This virtual congress was taking place on April 27-29th, with 3 days of…
Read more
General / Protéus
CPhI Webinar series : Enzymes & Biocatalysis for Green Chemistry
On April 28th, during the Webinar Series « Green chemistry : Inspiring sustainable drug manufacturing » organized by CPhI, Julien Boutet, Innovation Manager at…
Read more
Protéus
High performance enzyme ready for shipment
Protéus by Seqens’ team has recently developed and produced a highly efficient enzyme. It is operated for the biocatalytic production of…
Read more
Protéus
Focus on : Precious transition metal catalysts replacement
During the last 5 years, large price increases were observed for precious transition metal catalysts: Palladium price has increased by a factor…
Read more
Products & Technologies / Protéus
Biocatalyst for Sucrose conversion into Fructo-Oligosaccharides
Sugar-reduction in food is at the heart of everyone’s concerns. Fructo OligoSaccharides (FOS) are a natural sweet-tasting, low-calorie alternative that is widely…
Read more
Protéus / SD-CSR
Protéus by Seqens is now certified Gold Ecovadis
Protéus-By-Seqens team, located in Nîmes (France), is pleased to announce having achieved the “Gold” level following the evaluation of its Corporate Social…
Read more
General / Protéus / SD-CSR
Protéus by Seqens winner of the Potier Prize 2020
This year, the Pierre Potier 2020 prize was awarded to Protéus by Seqens, the group’s biotech subsidiary specialized in enzymatic biocatalysis,…
Read more
Protéus
Conference: “Biocatalysis from lab to industrial scale”
On July 27th, during the Protein Engineering Congress USA, Protéus by Seqens gave a talk on « Biocatalysis from lab to industrial scale », right…
Read more
General / Protéus
Biocatalysis Webinar – Protéus by Seqens – Pôle IAR – May 6th, 2020
REPLAY OF THE WEBINAR About BIOCATALYSIS On May 6th, Proteus by Seqens co-organized, together with the French bioeconomy cluster IAR a webinar on…
Read more
General / Protéus
A new article published by Proteus in the special issue of OPRD journal
engineering of enzymatic cascades from D-serine This special issue highlights innovative organic chemistry research from academic and industrial chemists across France and its…
Read more